Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "ELOVL fatty acid elongase 6 pseudogene" refers to a genomic DNA sequence that shares high similarity with the protein-coding ELOVL6 gene but does not encode a functional enzyme. Unlike the ELOVL6 gene, which catalyzes the elongation of saturated and monounsaturated fatty acids and plays key roles in lipid metabolism, the pseudogene is transcriptionally inactive and does not contribute to lipid biosynthesis or any known metabolic or signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ELOVL fatty acid elongase 6 pseudogene.